Company Filing History:
2 out of 536 
1 out of 199 
2 out of 832,891 Years Active: 2013-2022
Title: The Innovative Contributions of Gary Kobinger
Introduction
Gary Kobinger is a prominent inventor based in Winnipeg, Canada. He has made significant strides in the field of vaccine development, particularly in relation to viral pathogens. With a total of 5 patents to his name, Kobinger's work has the potential to impact public health on a global scale.
Latest Patents
Kobinger's latest patents focus on groundbreaking approaches to vaccine development. One notable invention is the Ebola virus and Marburg virus glycoprotein mucin-like domain replacement expression system. This system utilizes a series of Ebola virus envelope glycoprotein (EboGP)-based chimeric fusion proteins. These proteins maintain efficient EboGP-mediated virus entry in various cell types, including human antigen-presenting cells (APCs). They also present large viral polypeptides, such as the HIV Env v3-v5 domain, to elicit robust host immune responses. This invention demonstrates the feasibility of EboGP-based chimeric fusion technology as a novel vaccine approach against various microbial pathogens and cancers. Another significant patent involves peptide adjuvants, which are compositions comprising specific 5mer polypeptides combined with antigen delivery systems and immunostimulatory molecules. These adjuvants enhance the immune response of coadministered antigens.
Career Highlights
Throughout his career, Kobinger has worked with notable organizations, including Her Majesty the Queen in Right of Canada, as represented by the Minister. His contributions to vaccine research and development have positioned him as a leader in the field.
Collaborations
Kobinger has collaborated with esteemed colleagues, including Ami Patel and Darwyn Kobasa. These partnerships have furthered his research and innovation in vaccine technology.
Conclusion
Gary Kobinger's innovative work in vaccine development showcases his commitment to advancing public health. His patents and collaborations highlight the importance of scientific research in combating viral diseases.